Playside Studios (ASX:PLY) - CEO, Gerry Sakkas
CEO, Gerry Sakkas
Source: The Sydney Morning Herald
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Playside Studios (PLY) has closed a heavily oversubscribed $3 million share purchase plan (SPP)
  • The company’s strongly supported SPP received total subscriptions of just under $13 million, in addition to a successful $25 million placement
  • Funds raised will be used towards work-for-hire execution, a new studio location on the Gold Coast and metaverse and blockchain research and development
  • The SPP offer invited eligible shareholders to invest up to a maximum of $30,000 per shareholder at an issue price of 75 cents each
  • Company shares are up 1.8 per cent at 85 cents 

Playside Studios (PLY) has closed a heavily oversubscribed $3 million share purchase plan (SPP). 

The company’s strongly supported SPP received total subscriptions of around $13 million, in addition to a successful $25 million placement. 

Funds raised from both the placement and SPP will be used towards work-for-hire execution, a new studio location on the Gold Coast with team expansion and metaverse and blockchain research and development. 

The SPP offer invited eligible shareholders to invest up to a maximum of $30,000 per shareholder, at an issue price of 75 cents each.

In accordance with the SPP terms, the directors conducted a scale back of the proceeds which were made on a pro-rata basis.

This process will result in 4 million new shares issued for a total of $3 million cash received.

Playside sais it anticipates holding statements and refund advices would be received by all shareholders in the week beginning Monday December 13.

“We are very pleased with the applications received under the SPP and would like to thank our existing shareholders for their ongoing support,” Playside Studios CEO Gerry Sakkas said.

Company shares are up 1.8 per cent at 85 cents at 1:19 pm AEDT. 

PLY by the numbers
More From The Market Online

Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans

Telix Pharmaceuticals has submitted a new drug application to the United States Food and Drug Administration…

Hammer Metals inks earn-in deal with South 32 for Isa Valley copper play

Microcap Hammer Metals has announced its execution of an earn-in agreement with mining giant South 32…

High-grade gossans with VMS potential impress Dreadnought in WA

Dreadnought Resources Ltd has identified gossans with high grades of precious and base metals at the…

Market Open: ASX set to rise as green US Friday boosts morale

Good morning and welcome to the start of Week 22. The ASX200 is set to rise…